ESR1 and breast cancer: In 2017, Zañudo et al. established a discrete dynamical model of the signal transduction processes involved in the PI3K mutant, estrogen receptor positive (ER+) breast cancer, as shown in Figure 4 (Gómez Tejeda Zañudo et al., 2017).